NCT02058992View on ClinicalTrials.gov

Ramelteon Tablets 8mg Drug Use Surveillance: Survey on Insomnia Associated With Sleep-onset Difficulty

CompletedOBSERVATIONAL
Enrollment

3,339

Participants

Timeline

Start Date

July 31, 2010

Primary Completion Date

April 30, 2013

Study Completion Date

April 30, 2013

Conditions
Insomnia
Interventions
DRUG

Ramelteon

Ramelteon 8 mg tablets

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY

NCT02058992 - Ramelteon Tablets 8mg Drug Use Surveillance: Survey on Insomnia Associated With Sleep-onset Difficulty | Biotech Hunter | Biotech Hunter